Table 1 Demographic characteristics.

From: Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion

 

nAMD

DMO

BRVO

HRVO

CRVO

Eyes, n

3802

975

357

54

371

Patients, n

3284

718

351

54

368

Female, n (%)

2012 (61)

259 (36)

185 (53)

23 (43)

167 (45)

Right Eye, n (%)

1957 (52)

501 (51)

195 (55)

24 (44)

194 (52)

Age years, mean (SD)

80 (9)

63 (12)

71 (12)

73 (11)

72 (13)

Baseline VA letters, mean (SD)

59.2 (20)

65.4 (16.8)

58 (18)

47.9 (23.9)

42 (26)

VA ≥ 69 letters, %

41

56

33

26

17

VA ≤ 35 Less, %

14

7

12

32

39

CST, µm (SD)

415 (126)

472 (156)

576 (212)

624 (229)

Lesion, %

CNV lesion type

DMO type

Ischaemia

Ischaemia

Ischaemia, %

 

Type 1—41

Type 2—17

Type 3—5

Other—5

Not done—32

Centre-involving—88

Non centre-involving—9

No CSME—3

Macular—5

Peripheral—13

Macular—4

Peripheral—30

Macular—6

Peripheral—21

  1. nAMD Neovascular age-related macular degeneration, DMO Diabetic macular oedema, BRVO Branch retinal vein occlusion, HRVO Hemi-retinal vein occlusion, CRVO Central retinal vein occlusion, n number, SD standard deviation, DR Diabetic retinopathy, VA visual Acuity, CST Central subfield thickness, CNV Choroidal neovascularization.